Autoantibodies against modified low-density lipoproteins in coronary artery disease

Atherosclerosis

Volumn 167, Issue 2, 2003, Pages 347-353

  Tornvall, Per ^a   Waeg, Georg ^b   Nilsson, Jan ^c   Hamsten, Anders ^a   Regnström, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GRAZ   (Austria)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoantibodies; Coronary angiography; Modified low density lipoprotein; Myocardial infarction; Prognosis

Indexed keywords

AUTOANTIBODY; COPPER; HYPOCHLORITE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE;

ADULT; ANGIOCARDIOGRAPHY; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FOLLOW UP; HEART PROTECTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0038463522     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00021-2     Document Type: Article

References (25)

1. Ross R. Atherosclerosis - an inflammatory disease. New Engl. J. Med. 340:1999;115-126.
2. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 98:1998;1487-1494.
3. Holvoet P., Stassen J.-M., Van Cleemput J., Collen D., Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18:1998;100-107.
4. Toshima S.-I., Hasegawa A., Kurabayashi M., et al. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 20:2000;2243-2247.
5. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low density lipoproteins show a positive relationship with the severity of acute coronary syndromes. Circulation. 103:2001;1955-1960.
6. Virella I., Leman R., Virella G., Pryor M., Lopes-Virella M. Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int. J. Clin. Lab. Res. 23:1993;95-101.
7. Maggi E., Finardi G., Poli M., et al. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk. Coron. Artery Dis. 4:1993;1119-1122.
8. Armstrong V., Wieland E., Diedrich F., et al. Serum antibodies to oxidized low-density lipprotein in pre-eclampsia and coronary heart disease. Lancet. 343:1994;1560.
9. Puurunen M., Manttari M., Manninen V., et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch. Intern. Med. 154:1994;2605-2609.
10. Boullier A., Hamon M., Walters-Laporte E., et al. Detection of autoantibodies against oxidized low-density lipproteins in patients with coronary artery disease. Clin. Chim. Acta. 238:1995;1-10.
11. van de Vijver L.P., Steyger R., van Poppel G., Boer J.M., Kruijssen D.A., Seidell J.C., Princen H.M. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis. 122:1996;245-253.
12. Wu R., Nityanand S., Beglind L., Lithell H., Holm G., Lefvert A.K. Antibodies against cardiolipin and oxidatively modified LSL in 50-year-old men predict myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 17:1997;3159-3163.
13. Lehtimaki T., Lehtinen S., Solakivi T., et al. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 19:1999;23-27.
14. Fukumoto M., Shoji T., Emoto M., Kawagishi T., Okuno Y., Nishizawa Y. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler. Thromb. Vasc. Biol. 20:2000;703-707.
15. Hulthe J., Bokemark L., Fagerberg B. Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-years-old subjectively clinically healthy men. Arterioscler. Thromb. Vasc. Biol. 21:2001;101-107.
16. Salonen J., Yla-Herttuala S., Yamamoto R., et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
17. Moor E., Silverira A., van't Hooft F., Sountaka A.M., Eriksson P., Blomback M., Hamsten A. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype. Arterioscler. Thromb. Vasc. Biol. 15:1995;655-664.
18. Carlsson K. Lipoprotein fractionation. J. Clin. Pathol. 5:1973;32-34.
19. Hamsten A., Walldius G., Szamosi A., Dahlen G., deFaire U. Relationship of angiographically defined coronary artery disease to serum lipoproteins an apolipoproteins in young survivors of myocardial infarction. Circulation. 73:1986;1097-1110.
20. Monaco C., Crea F., Niccoli G., et al. Autoantibodies against oxidized low density lipoproteins in patients with stable angina unstable angina or peripheral vascular disease. Eur. Heart J. 22:2001;1572-1577.
21. Ameli S., Hultgardh-Nilsson A., Regnstrom J., et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. 16:1996;1074-1079.
22. Shoji T., Nishizawa Y., Fukumoto M., et al. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis. 148:2000;171-177.
23. Powell J.T. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc. Med. 3:1998;21-28.
24. Liu C.-S., Lii C.-K., Ou C.-C., Tsai C.-H., Wei Y.-H., Chen H.-W. Autoantibody against oxidized low-density lipoproteins may be enhanced by cigarette smoking. Chem. Biol. Interact. 127:2000;125-137.
25. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97:1996;1535-1544.